Lexaria Bioscience Corp
General ticker "LEXX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $31.4M
Lexaria Bioscience Corp follows the US Stock Market performance with the rate: 8.9%.
Estimated limits based on current volatility of 2.5%: low 2.11$, high 2.22$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-08-31 to 2026-08-31
- 2024-08-31 to 2025-08-31 estimated range: [2.03$, 5.39$]
- 2025-08-31 to 2026-08-31 estimated range: [1.56$, 4.33$]
Short-term LEXX quotes
Long-term LEXX plot with estimates
Financial data
| YTD | 2022-08-31 | 2023-08-31 | 2024-08-31 |
|---|---|---|---|
| Operating Revenue | $0.26MM | $0.23MM | $0.46MM |
| Operating Expenses | $7.64MM | $6.76MM | $6.22MM |
| Operating Income | $-7.38MM | $-6.53MM | $-5.75MM |
| Non-Operating Income | $0.00MM | $-0.22MM | $-0.04MM |
| R&D Expense | $1.84MM | $3.67MM | $2.36MM |
| Income(Loss) | $-7.38MM | $-6.76MM | $-5.80MM |
| Profit(Loss) | $-7.38MM | $-6.76MM | $-5.80MM |
| Stockholders Equity | $7.95MM | $3.04MM | $8.04MM |
| Inventory | $0.04MM | $0.00MM | $0.00MM |
| Assets | $7.83MM | $3.08MM | $8.87MM |
| Operating Cash Flow | $-4.88MM | $-5.88MM | $-4.96MM |
| Capital expenditure | $0.13MM | $0.17MM | $0.04MM |
| Investing Cash Flow | $-0.18MM | $-0.17MM | $-0.19MM |
| Financing Cash Flow | $-0.04MM | $1.59MM | $10.32MM |
| Earnings Per Share* | $-1.24 | $-1.01 | $-0.47 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.